Editorial: Smoking cessation and Alzheimer's disease: Facts, fallacies and promise

Expert Review of Neurotherapeutics

Volumn 10, Issue 5, 2010, Pages 629-631

  Cataldo, Janine K ^a   Glantz, Stanton A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; GERIATRICS; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HYPERTENSION; LIPID PEROXIDATION; OXIDATIVE STRESS; QUALITY OF LIFE; SMOKING CESSATION; STROKE; HUMAN; RISK FACTOR; SMOKING;

ALZHEIMER DISEASE; HUMANS; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 77951877038     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.34     Document Type: Editorial

References (26)

1. Brookmeyer R. Forecasting the global prevalence and burden of Alzheimer's disease. Alzheimers Dement. 3 (3), 186-191 (2007). (Pubitemid 46825511)
2. Cataldo JK, Prochaska J, Glantz S. Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affliation. J. Alzheimers Dis. 19 (2), 465-480 (2010).
3. Appel SH. Alzheimer's disease. In: Brain Neurotransmitters and Receptors in Aging and Age Related Disorders. Enna SJ (Ed.). Raven Press, NY, USA (1981).
4. Mondragón-Rodríguez S, Basurto-Islas G, Lee H-G et al. Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev. Neurother. 10 (5), 683-691 (2010).
5. Burke A, FitzGerald GG. Oxidative stress and smoking-induced vascular injury. Prog. Cardiovasc. Dis. 46 (1), 79-90 (2003). (Pubitemid 37013220)
6. Halliwell B, Gutteridge J. Oxidative Stress: Adaptation, Damage, Repair and Death. Oxford University Press, Oxford, UK (1999).
7. Isik B, Ceylan A, Isik R. Oxidative stress in smokers and non-smokers. Inhal. Toxicol. 19 (9), 767-769 (2007). (Pubitemid 47026974)
8. Polidori MC, Griffths HR, Mariani E, Mecocci P. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease. Amino Acids 32 (4), 553-559 (2007). (Pubitemid 46790937)
9. Fillit H, Nash DT, Rundek T, Zuckerman A. Cardiovascular risk factors and dementia. Am. J. Geriatric Pharmacother. 6 (2), 100 (2008).
10. Iadecola C, Gorelick PP. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke 34 (2), 335 (2003). (Pubitemid 36206315)
11. Gorelick PP. Risk factors for vascular dementia and Alzheimer disease. Stroke 35, 2620-2622 (2004). (Pubitemid 39458352)
12. Polidori MC, Mecocci P, Stahl W, Sies H. Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge. Br. J. Nutr. 90 (1), 147-150 (2007). (Pubitemid 36903412)
13. Naschitz JE, Rosner I, Rozenbaum M et al. Patterns of cardiovascular reactivity in disease diagnosis. Q JM 97 (3), 141-151 (2004). (Pubitemid 38351263)
14. Regan C, Katona C, Walker Z, Hooper J, Donovan J, Livingston G. Relationship of vascular risk to the progression of Alzheimer disease. Neurology 67 (8), 1357 (2006). (Pubitemid 44632057)
15. Silvestrini M, Pasqualetti P, Baruffaldi R et al. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 37 (4), 1010 (2006).
16. Mielke MM, Rosenberg PB, Tschanz J et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology 69 (19), 1850 (2007). (Pubitemid 350071146)
17. Dochi M, Sakata K, Oishi M, Tanaka K, Kobayashi E, Suwazono Y. Smoking as an independent risk factor for hypertension: a 14-year longitudinal study in male Japanese workers. Tohoku J. Exp. Med. 217 (1), 37-43 (2009).
18. Heeringa J, Kors JA, Hofman A, van Rooij FJA, Witteman J. Cigarette smoking and risk of atrial fbrillation: the Rotterdam Study. Am. Heart J. 156 (6), 1163 (2008).
19. Ding EL, Hu FF. Smoking and Type 2 diabetes: underrecognized risks and disease burden. JAMA 298 (22), 2675 (2007).
20. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. Br. Med. J. 298 (6676), 789 (1989). (Pubitemid 19084523)
21. Deschaintre Y, Richard F, Leys D, Pasquier F. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology 73 (9), 674 (2009).
22. Andersen K. Cost of dementia: impact of disease progression estimated in longitudinal data. Scand. J. Public Health 31 (2), 119 (2003). (Pubitemid 41007524)
23. Cataldo JJ. Clinical implications of smoking and aging: breaking through the barriers. J. Gerontol. Nursing 33 (8), 32 (2007).
24. Lightwood JM, Glantz SS. Short-term economic and health benefts of smoking cessation: myocardial infarction and stroke. Circulation 96 (4), 1089 (1997).
25. Lightwood J, Fleischmann KE, Glantz SS. Smoking cessation in heart failure: it is never too late. J. Am. Coll. Cardiol. 37 (6), 1683-1684 (2001).
26. Buckland A, Connolly MM. Age-related differences in smoking cessation advice and support given to patients hospitalised with smoking-related illness. Age Ageing 34 (6), 639 (2005). (Pubitemid 41700011)